Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1252 participants.
Also called NCT04763200
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,252 participants
- Sponsor
- Registry
-
NCT04763200
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, Italy, Netherlands, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04763200. Randomized; no masking; primary purpose treatment. Start 2021-04-13 (actual); primary completion 2026-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
- Acronym
- PROTECT IV
- Condition
- Left Ventricular Dysfunction
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
- Intervention (Device)
- IABP Intra-aortic balloon pump
- Lead sponsor
- Abiomed Inc.
Record details
- Record id
cardio:ct-nct04763200- Content hash
897f5e2ab72cf3f6679337bb5f2cf0129e03c37c2f4caa2bd02a102816c083db